Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Summit Therapeutics Plc (SMMTUSD)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2018 Q2 | 194,900 | <0.01 | $2.45 | $478,000 | SEC | ||
| 2018 Q1 | 194,900 | 0.01 | $12.90 | $2,514,000 | SEC | ||
| 2017 Q4 | 194,900 | 0.01 | Add 11.44% | <0.01 | $11.08 | $2,159,000 | SEC |
| 2017 Q3 | 174,900 | <0.01 | $12.52 | $2,190,000 | SEC | ||
| 2017 Q2 | 174,900 | <0.01 | $10.99 | $1,922,000 | SEC | ||
| 2017 Q1 | 174,900 | 0.01 | Reduce 0.06% | $13.34 | $2,333,000 | SEC | |
| 2016 Q4 | 175,000 | <0.01 | $8.56 | $1,498,000 | SEC | ||
| 2016 Q3 | 175,000 | <0.01 | $9.18 | $1,607,000 | SEC | ||
| 2016 Q2 | 175,000 | <0.01 | $7.91 | $1,384,000 | SEC | ||
| 2016 Q1 | 175,000 | <0.01 | $7.00 | $1,225,000 | SEC | ||
| 2015 Q4 | 175,000 | 0.01 | $11.48 | $2,009,000 | SEC | ||
| 2015 Q3 | 175,000 | <0.01 | $10.41 | $1,822,000 | SEC | ||
| 2015 Q2 | 175,000 | <0.01 | $11.11 | $1,944,000 | SEC | ||
| 2015 Q1 | 175,000 | 0.01 | Buy | 0.01 | $12.39 | $2,168,000 | SEC |